These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 11923684

  • 1. Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates.
    Ringers J, Haanstra KG, Kroczek RA, Kliem K, Kuhn EM, Wubben J, Ossevoort MA, Volk HD, Jonker M.
    Transplantation; 2002 Mar 27; 73(6):862-6. PubMed ID: 11923684
    [Abstract] [Full Text] [Related]

  • 2. Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.
    Elster EA, Xu H, Tadaki DK, Montgomery S, Burkly LC, Berning JD, Baumgartner RE, Cruzata F, Marx R, Harlan DM, Kirk AD.
    Transplantation; 2001 Nov 15; 72(9):1473-8. PubMed ID: 11707732
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN, Mordes JP, Markees TG, Phillips NE, Rossini AA, Greiner DL.
    J Immunol; 2000 Jan 01; 164(1):512-21. PubMed ID: 10605049
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance.
    Phillips NE, Markees TG, Mordes JP, Greiner DL, Rossini AA.
    J Immunol; 2003 Mar 15; 170(6):3015-23. PubMed ID: 12626555
    [Abstract] [Full Text] [Related]

  • 8. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
    Yuan X, Dong VM, Coito AJ, Waaga AM, Salama AD, Benjamin CD, Sayegh MH, Chandraker A.
    Transplantation; 2002 Jun 15; 73(11):1736-42. PubMed ID: 12084995
    [Abstract] [Full Text] [Related]

  • 9. CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival.
    Liu H, Qiu F, Wang Y, Zeng Q, Liu C, Chen Y, Liang CL, Zhang Q, Han L, Dai Z.
    Front Immunol; 2019 Jun 15; 10():306. PubMed ID: 30863408
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model.
    Kanmaz T, Fechner JJ, Torrealba J, Kim HT, Dong Y, Oberley TD, Schultz JM, Bloom DD, Katayama M, Dar W, Markovits J, Schuler W, Hu H, Hamawy MM, Knechtle SJ.
    Transplantation; 2004 Mar 27; 77(6):914-20. PubMed ID: 15077037
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Impact of both donor and recipient strains on cardiac allograft survival after blockade of the CD40-CD154 costimulatory pathway.
    van Maurik A, Wood KJ, Jones ND.
    Transplantation; 2002 Sep 15; 74(5):740-3. PubMed ID: 12352896
    [Abstract] [Full Text] [Related]

  • 15. Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation.
    Montgomery SP, Xu H, Tadaki DK, Celniker A, Burkly LC, Berning JD, Cruzata F, Elster EA, Gray G, Kampen RL, Swanson SJ, Harlan DM, Kirk AD.
    Transplantation; 2002 Nov 27; 74(10):1365-9. PubMed ID: 12451232
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates.
    Preston EH, Xu H, Dhanireddy KK, Pearl JP, Leopardi FV, Starost MF, Hale DA, Kirk AD.
    Am J Transplant; 2005 May 27; 5(5):1032-41. PubMed ID: 15816883
    [Abstract] [Full Text] [Related]

  • 18. Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients.
    Cho CS, Burkly LC, Fechner JH, Kirk AD, Oberley TD, Dong Y, Brunner KG, Peters D, Tenhoor CN, Nadeau K, Yagci G, Ishido N, Schultz JM, Tsuchida M, Hamawy MM, Knechtle SJ.
    Transplantation; 2001 Aug 27; 72(4):587-97. PubMed ID: 11544416
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential induction of donor-reactive Foxp3+ regulatory T cell via blockade of CD154 vs CD40.
    Liu D, Yao H, Ferrer IR, Ford ML.
    Am J Transplant; 2024 Aug 27; 24(8):1369-1381. PubMed ID: 38552961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.